All Stories

  1. Airway remodeling disease: primary human structural cells and phenotypic and pathway assays to identify targets with potential to prevent or reverse remodeling

    Article • Journal of Experimental Pharmacology, November 2018, Dove Medical Press

    Elizabeth Rosethorne

  2. Endogenous lysophosphatidic acid (LPA1) receptor agonists demonstrate ligand bias between calcium and ERK signalling pathways in human lung fibroblasts

    Article • British Journal of Pharmacology, January 2017, Wiley

    Elizabeth Rosethorne